Apr 23, 2020
Johnson & Johnson Announces Collaboration to Expand Manufacturing Capabilities For its COVID-19 Vaccine Candidate in Support of the Company's Goal to Supply More Than One Billion Vaccine Doses Globally
Apr 15, 2020
Three Chinese Vaccines against COVID-19 are on the Way
Apr 07, 2020
15 Prominent Pharma Companies in Vaccine Developments for COVID-19 - ResearchAndMarkets.com
Apr 02, 2020
Seed of hope: COVID-19 vaccine trials begin
Mar 30, 2020
Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use
Mar 11, 2020
Greffex, Inc. Completes COVID-19 Vaccine and Prepares for Testing
Jan 14, 2020
Soligenix - Advancing to Important Inflection Points With Two Pivotal Phase 3 Clinical Trials
Dec 08, 2019
Johnson & Johnson Announces Commitment to Support Republic of Rwanda's Preparedness Against Ebola Outbreak
Oct 31, 2019
Johnson & Johnson Announces Donation of up to 500,000 Regimens of Janssen's Investigational Ebola Vaccine to Support Outbreak Response in Democratic Republic of the Congo (DRC)
Jul 31, 2019
Soligenix Announces Conference Presentations Demonstrating Formulations of Single and Multivalent Ebola Subunit Vaccines
Mar 21, 2019
Inovio's Ebola Vaccine Delivered Intradermally Demonstrates 100% Immunogenicity in a Clinical Study Published in The Journal of Infectious Diseases
Feb 07, 2019
Soligenix Announces Publication Demonstrating Thermostabilization of an Ebola Subunit Vaccine Candidate
Jan 28, 2019
NIAID-Sponsored Clinical Trial of Ebola Vaccines Begins at Cincinnati Children's
Jan 11, 2019
Global Emerging Infectious Diseases Vaccine Markets 2018-2019: Focus on Ebola Vaccine Pipeline, Zika Vaccine Pipeline & MERS-CoV Vaccine Pipeline
Dec 07, 2018
Global Human Vaccines Strategic Business Report 2018: Analysis & Forecast 2016-2024 - Market Trends & Issues
Aug 21, 2018
Vaccines Market - Global Forecast to 2023: Increasing Company Initiatives to Enhance R&D are Driving the Vaccines Market
Jul 19, 2018
Soligenix - Driving Towards Key Inflection Points with Two Pivotal Phase 3 Clinical Trials
May 30, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., on federal preparedness and FDA's response efforts to the Ebola virus outbreak in the Democratic Republic of Congo
Mar 20, 2018
National Research Council contribution plays key role in newly approved Ebola vaccine
Jan 25, 2018
Soligenix - Driving Towards Key Inflection Points with Two Pivotal Phase 3 Clinical Trials